Pharmalundensis
Manufacturing · Sweden · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Scheelevagen 2, Lund, Skane, SE-223 81, ...Phone Number
+46 46132780Website
www.pharmalundensis.seRevenue
<$5 MillionIndustry
About Pharmalundensis
Is Pharmalundensis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Pharmalundensis, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Pharmalundensis
Check out if Pharmalundensis is spiking on competitors!
Earning: See what the market has to say on Pharmalundensis recently announced quarterly report
Product Launch: Get notified when Pharmalundensis launches new products
Click to see if Pharmalundensis had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Pharmalundensis has new funding data
Check if Pharmalundensis has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Pharmalundensis is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Pharmalundensis is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Pharmalundensis.
Pharmalundensis Tech Stack
A closer look at the technologies used by Pharmalundensis
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Pharmalundensis
PharmaLundensis develops pharmaceuticals that bind and excrete heavy metals such as mercury, lead, and cadmium from the body, aiming to improve health in various diseases. Their lead product, Phal-501, is expected to be an effective antidote for methylmercury, a potent neurotoxin found in contaminated food sources. The company targets patients suff... Read More